Komori
CellSource (4880) · PolicyRestated

Respect for Stakeholder Interests and the Enhancement of Long-Term Corporate Value

First written in FY2019. 3 of 4 entries say "Restated". Latest entry: FY2022.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20222020: 120202021: 120212022: 120222023: 1
Same theme, other companies
Maximizing Corporate Value for All StakeholdersA theme 138 companies write about · 0 as a headwind · 140 as a tailwind

109 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 138 companies compared. The sentences above are computed from all 138.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「The company positions corporate governance as the foundation of its business, essential to generating ongoing earnings and enhancing sustainability, and aims to synchronize social sustainability with corporate sustainability.」

    The company continues to pursue a governance philosophy that balances delivering value to stakeholders with the sustainability of the company and society.
  2. FY2021RestatedAnnual report

    「Maximize respect for the combined interests of all stakeholders, including shareholders, employees, business partners, patients of affiliated medical institutions, consumers and local communities, and provide fair and prompt information disclosure.」

    The company continues to uphold the interests of a broad range of stakeholders, provide fair and prompt information disclosure, and enhance corporate value.
  3. FY2020RestatedAnnual report

    「Maximize respect for the combined interests of all stakeholders, including shareholders, employees, business partners, patients of affiliated medical institutions, consumers and local communities, and provide fair and prompt information disclosure.」

    The company continues to uphold the interests of a broad range of stakeholders, provide fair and prompt information disclosure, and expand long-term corporate value.
  4. FY2019First statedAnnual report

    「We will maximise respect for the collective interests of all stakeholders, including shareholders, employees, business partners, patients of partner medical institutions, consumers and local communities, provide fair and prompt disclosure of information, and simultaneously achieve innovative, sustainable growth and a long-term, stable increase in corporate value」

    As a basic approach to corporate governance, the Company seeks to balance the interests of a broad range of stakeholders with corporate value.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CellSource yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Respect for Stakeholder Interests and the Enhancement of Long-Term Corporate Value | CellSource Co.,Ltd. (4880) | Komori